Advancements in Dermatology: A Weekly Review
Dermatologia e Venerologia
Breakthroughs in Dermatology: From Psoriasis to Scabies
This week's episode covers groundbreaking research in dermatology, including new treatments for psoriasis, advances in disease modeling, and important case reports highlighting diagnostic challenges and treatment considerations.
Bibliography
1. Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials.
Authors: Stein Gold L, Armstrong AW, Soung J, et al.
Journal: The British journal of dermatology, 2026 Sep 18
PMID: 42397072
DOI: 10.1093/bjd/ljag264
2. Advantages and limitations of in vitro models for atopic dermatitis: A consensus expert opinion.
Authors: Peters RHW, Smits JPH, van den Bogaard EH, et al.
Journal: The Journal of investigative dermatology, 2026 Oct
PMID: 42246919
DOI: 10.1016/j.jid.2026.04.032
3. Crusted scabies following tralokinumab and systemic corticosteroid treatment for presumed atopic dermatitis.
Authors: Turan TL, Rochín LMC, Blume-Peytavi U, et al.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2026 Oct
PMID: 42462997
DOI: 10.1016/j.ijid.2026.108984
4. The Gut Microbiome as a Therapeutic Target in Alopecia Areata: Not Yet Part of the Patient Treatment Plan.
Authors: McMullen E, Hafeez DA, Pai N, et al.
Journal: International journal of dermatology, 2026 Oct
PMID: 41999025
DOI: 10.1111/ijd.70437
5. Immune-checkpoint inhibitor-induced bullous pemphigoid in patients with metastatic renal cell carcinoma: two case reports and systematic review of the literature.
Authors: Filis P, Lindskog M, Curman P, et al.
Journal: Acta oncologica (Stockholm, Sweden), 2026 Sep 9
PMID: 42714143
DOI: 10.2340/1651-226X.2026.46088
6. The Role of Tissue Resident Memory Cells in Immunodermatological Disorders.
Authors: De A, Chakraborty D, Desai S, et al.
Journal: International journal of dermatology, 2026 Oct
PMID: 42473984
DOI: 10.1111/ijd.70594
7. Simulated daylight versus conventional PDT for mild to moderate actinic keratoses: A randomized controlled trial.
Authors: Sjöholm A, Backman E, Modin M, et al.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV, 2026 Oct
PMID: 42266064
DOI: 10.1111/jdv.70556
8. Darier disease-A review highlighting new insights from the Darier Disease International Task Force.
Authors: Labbouz S, Hovnanian A, Xiong G, et al.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV, 2026 Oct
PMID: 42223188
DOI: 10.1111/jdv.70483
9. Position Statement of the EADV Task Forces With External Experts on Quality of Life Measurement in Hidradenitis Suppurativa: An Update.
Authors: Chernyshov PV, Jemec G, Finlay A, et al.
Journal: International journal of dermatology, 2026 Oct
PMID: 42144705
DOI: 10.1111/ijd.70443
10. Fatal Cutaneous Mucormycosis Initially Misdiagnosed as Necrotizing Fasciitis in an Uncontrolled Diabetic Patient: A Case Report Highlighting Diagnostic Delay.
Authors: Hartantri Y, Gunadi SV, Ferdian F, et al.
Journal: International medical case reports journal, 2026
PMID: 42780669
DOI: 10.2147/IMCRJ.S612465
Authors: Stein Gold L, Armstrong AW, Soung J, et al.
Journal: The British journal of dermatology, 2026 Sep 18
PMID: 42397072
DOI: 10.1093/bjd/ljag264
2. Advantages and limitations of in vitro models for atopic dermatitis: A consensus expert opinion.
Authors: Peters RHW, Smits JPH, van den Bogaard EH, et al.
Journal: The Journal of investigative dermatology, 2026 Oct
PMID: 42246919
DOI: 10.1016/j.jid.2026.04.032
3. Crusted scabies following tralokinumab and systemic corticosteroid treatment for presumed atopic dermatitis.
Authors: Turan TL, Rochín LMC, Blume-Peytavi U, et al.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2026 Oct
PMID: 42462997
DOI: 10.1016/j.ijid.2026.108984
4. The Gut Microbiome as a Therapeutic Target in Alopecia Areata: Not Yet Part of the Patient Treatment Plan.
Authors: McMullen E, Hafeez DA, Pai N, et al.
Journal: International journal of dermatology, 2026 Oct
PMID: 41999025
DOI: 10.1111/ijd.70437
5. Immune-checkpoint inhibitor-induced bullous pemphigoid in patients with metastatic renal cell carcinoma: two case reports and systematic review of the literature.
Authors: Filis P, Lindskog M, Curman P, et al.
Journal: Acta oncologica (Stockholm, Sweden), 2026 Sep 9
PMID: 42714143
DOI: 10.2340/1651-226X.2026.46088
6. The Role of Tissue Resident Memory Cells in Immunodermatological Disorders.
Authors: De A, Chakraborty D, Desai S, et al.
Journal: International journal of dermatology, 2026 Oct
PMID: 42473984
DOI: 10.1111/ijd.70594
7. Simulated daylight versus conventional PDT for mild to moderate actinic keratoses: A randomized controlled trial.
Authors: Sjöholm A, Backman E, Modin M, et al.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV, 2026 Oct
PMID: 42266064
DOI: 10.1111/jdv.70556
8. Darier disease-A review highlighting new insights from the Darier Disease International Task Force.
Authors: Labbouz S, Hovnanian A, Xiong G, et al.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV, 2026 Oct
PMID: 42223188
DOI: 10.1111/jdv.70483
9. Position Statement of the EADV Task Forces With External Experts on Quality of Life Measurement in Hidradenitis Suppurativa: An Update.
Authors: Chernyshov PV, Jemec G, Finlay A, et al.
Journal: International journal of dermatology, 2026 Oct
PMID: 42144705
DOI: 10.1111/ijd.70443
10. Fatal Cutaneous Mucormycosis Initially Misdiagnosed as Necrotizing Fasciitis in an Uncontrolled Diabetic Patient: A Case Report Highlighting Diagnostic Delay.
Authors: Hartantri Y, Gunadi SV, Ferdian F, et al.
Journal: International medical case reports journal, 2026
PMID: 42780669
DOI: 10.2147/IMCRJ.S612465
